Report Detail

Other Global Long-acting Injectable Medications Market Size, Status and Forecast 2020-2026

  • RnM4227711
  • |
  • 14 October, 2020
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 First-generation
    • 1.3.3 Second-generation
  • 1.4 Market by Application
    • 1.4.1 Global Long-acting Injectable Medications Market Share by Application: 2020 VS 2026
    • 1.4.2 Schizophrenia
    • 1.4.3 Contraception
    • 1.4.4 HIV
    • 1.4.5 Others
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Long-acting Injectable Medications Market Perspective (2015-2026)
  • 2.2 Long-acting Injectable Medications Growth Trends by Regions
    • 2.2.1 Long-acting Injectable Medications Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Long-acting Injectable Medications Historic Market Share by Regions (2015-2020)
    • 2.2.3 Long-acting Injectable Medications Forecasted Market Size by Regions (2021-2026)
  • 2.3 Long-acting Injectable Medications Industry Dynamic
    • 2.3.1 Long-acting Injectable Medications Market Trends
    • 2.3.2 Long-acting Injectable Medications Market Drivers
    • 2.3.3 Long-acting Injectable Medications Market Challenges
    • 2.3.4 Long-acting Injectable Medications Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Long-acting Injectable Medications Players by Market Size
    • 3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2015-2020)
    • 3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2015-2020)
  • 3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue
  • 3.4 Global Long-acting Injectable Medications Market Concentration Ratio
    • 3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2019
  • 3.5 Key Players Long-acting Injectable Medications Area Served
  • 3.6 Key Players Long-acting Injectable Medications Product Solution and Service
  • 3.7 Date of Enter into Long-acting Injectable Medications Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Long-acting Injectable Medications Breakdown Data by Type

  • 4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2015-2020)
  • 4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026)

5 Long-acting Injectable Medications Breakdown Data by Application

  • 5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2015-2020)
  • 5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Long-acting Injectable Medications Market Size (2015-2026)
  • 6.2 North America Long-acting Injectable Medications Market Size by Type (2015-2020)
  • 6.3 North America Long-acting Injectable Medications Market Size by Application (2015-2020)
  • 6.4 North America Long-acting Injectable Medications Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Long-acting Injectable Medications Market Size (2015-2026)
  • 7.2 Europe Long-acting Injectable Medications Market Size by Type (2015-2020)
  • 7.3 Europe Long-acting Injectable Medications Market Size by Application (2015-2020)
  • 7.4 Europe Long-acting Injectable Medications Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2015-2026)
  • 8.2 Asia-Pacific Long-acting Injectable Medications Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Long-acting Injectable Medications Market Size (2015-2026)
  • 9.2 Latin America Long-acting Injectable Medications Market Size by Type (2015-2020)
  • 9.3 Latin America Long-acting Injectable Medications Market Size by Application (2015-2020)
  • 9.4 Latin America Long-acting Injectable Medications Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2015-2026)
  • 10.2 Middle East & Africa Long-acting Injectable Medications Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Eli Lilly
    • 11.1.1 Eli Lilly Company Details
    • 11.1.2 Eli Lilly Business Overview
    • 11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
    • 11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2015-2020))
    • 11.1.5 Eli Lilly Recent Development
  • 11.2 Alkermes
    • 11.2.1 Alkermes Company Details
    • 11.2.2 Alkermes Business Overview
    • 11.2.3 Alkermes Long-acting Injectable Medications Introduction
    • 11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.2.5 Alkermes Recent Development
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Company Details
    • 11.3.2 Johnson & Johnson Business Overview
    • 11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
    • 11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.3.5 Johnson & Johnson Recent Development
  • 11.4 Zogenix
    • 11.4.1 Zogenix Company Details
    • 11.4.2 Zogenix Business Overview
    • 11.4.3 Zogenix Long-acting Injectable Medications Introduction
    • 11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.4.5 Zogenix Recent Development
  • 11.5 DURECT
    • 11.5.1 DURECT Company Details
    • 11.5.2 DURECT Business Overview
    • 11.5.3 DURECT Long-acting Injectable Medications Introduction
    • 11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.5.5 DURECT Recent Development
  • 11.6 Mapi Pharma
    • 11.6.1 Mapi Pharma Company Details
    • 11.6.2 Mapi Pharma Business Overview
    • 11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
    • 11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.6.5 Mapi Pharma Recent Development
  • 11.7 GSK
    • 11.7.1 GSK Company Details
    • 11.7.2 GSK Business Overview
    • 11.7.3 GSK Long-acting Injectable Medications Introduction
    • 11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.7.5 GSK Recent Development
  • 11.8 MedinCell
    • 11.8.1 MedinCell Company Details
    • 11.8.2 MedinCell Business Overview
    • 11.8.3 MedinCell Long-acting Injectable Medications Introduction
    • 11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.8.5 MedinCell Recent Development
  • 11.9 Oakwood Labs
    • 11.9.1 Oakwood Labs Company Details
    • 11.9.2 Oakwood Labs Business Overview
    • 11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
    • 11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.9.5 Oakwood Labs Recent Development
  • 11.10 Nanomi
    • 11.10.1 Nanomi Company Details
    • 11.10.2 Nanomi Business Overview
    • 11.10.3 Nanomi Long-acting Injectable Medications Introduction
    • 11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 11.10.5 Nanomi Recent Development
  • 11.11 Pharmathen
    • 10.11.1 Pharmathen Company Details
    • 10.11.2 Pharmathen Business Overview
    • 10.11.3 Pharmathen Long-acting Injectable Medications Introduction
    • 10.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 10.11.5 Pharmathen Recent Development
  • 11.12 Kashiv BioSciences
    • 10.12.1 Kashiv BioSciences Company Details
    • 10.12.2 Kashiv BioSciences Business Overview
    • 10.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
    • 10.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2015-2020)
    • 10.12.5 Kashiv BioSciences Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Long-acting Injectable Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long-acting Injectable Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    First-generation
    Second-generation

    Market segment by Application, split into
    Schizophrenia
    Contraception
    HIV
    Others

    Based on regional and country-level analysis, the Long-acting Injectable Medications market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Long-acting Injectable Medications market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Eli Lilly
    Alkermes
    Johnson & Johnson
    Zogenix
    DURECT
    Mapi Pharma
    GSK
    MedinCell
    Oakwood Labs
    Nanomi
    Pharmathen


    Summary:
    Get latest Market Research Reports on Long-acting Injectable Medications. Industry analysis & Market Report on Long-acting Injectable Medications is a syndicated market report, published as Global Long-acting Injectable Medications Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Long-acting Injectable Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,005.20
    4,507.81
    6,010.41
    3,316.12
    4,974.18
    6,632.24
    410,954.70
    616,432.05
    821,909.40
    285,963.99
    428,945.99
    571,927.98
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report